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The world’s poorer and less resourced
countries face a significant burden of
mental, neurological, and substance use
(MNS) disorders. This burden will contin-
ue to grow as the epidemiological transi-
tion—the process by which low and
middle countries see a rise in noncommu-
nicable diseases—gathers pace [1].
Recent reports on the care of persons
living with MNS disorders had two stark
findings. First, there is enormous inequity
in the distribution of specialist human
resources, both within and between coun-
tries [2]. One country alone (the US)
enjoys more psychiatrists than the world’s
most populous countries (India and China)
and an entire continent (Africa) put
together. Second, due to a combination
of factors including scarce resources, there
is an astonishingly large treatment gap for
people with MNS disorders. Worldwide at
least two-thirds of all persons with mental
illnesses, for example, go untreated, and in
low resource countries this figures exceeds
90% [3,4].
These findings sit alongside a compel-
ling evidence base indicating the strong
social determinants of MNS disorders and
the vicious cycle of deprivation and mental
ill-health [5]. Flagrant abuses of human
rights of people with MNS disorders have
been documented at every level of the
health system including, most disturbingly,
in the very institutions that are supposed to
cater to their needs [6]. In response to this
global health scandal, the recently
launched Movement for Global Mental
Health (www.globalmentalhealth.org) has
called for the immediate scaling up of
services for people with MNS disorders to
close the treatment gap, on the basis of
principles of evidence and human rights.
Which treatments should be scaled up
and how should these be delivered in
settings where specialists are scarce—a
common situation for the majority of the
global population? Starting this week, with
the article by Chowdhary and colleagues on
depression [7], PLoS Medicine publishes a
series of evidence-based reviews on packag-
es of care for six MNS disorders. We were
invited to be Guest Editors for this series.
Each review follows a set format: the focus is
on both the evidence of efficacy of specific
treatments, as well as how these should be
delivered. Indeed the routine delivery or
implementation of such interventions is of
vital importance. Therefore the series is
concerned not only with questions about the
treatments themselves (e.g., who should
provide these, and in what settings they be
provided), but also with improving access to
these treatments to achieve optimal long-
term clinical and social outcomes.
The six disorders are attention-deficit/
hyperactivity disorder (ADHD), epilepsy,
depression, schizophrenia, alcohol use dis-
orders, and dementia. These disorders
comprise the leading MNS causes of
disease burden across the life course. This
PLoS Medicine series is intended to be
entirely complementary to the new World
Health Organisation (WHO) Mental
Health Gap (mhGAP) initiative [8], which
will soon produce recommendations on the
use of specific treatments in primary and
community health care settings in low-
and middle-income countries (http://www.
who.int/mental_health/mhGAP/en/).
Although the specific treatments differ
between disorders, there are also many
shared themes related to the delivery of
these treatments. Detection and diagnosis
of more common disorders (such as
depression or alcohol use disorder) may
be reliably carried out using brief screen-
ing questionnaires. Less common disorders
(such as schizophrenia and dementia) may
need a two-stage case-finding procedure
with probable cases being identified
through community case-finding strategies
followed by a diagnostic interview by an
appropriately trained health worker. A
combined package of pharmacological
and psychosocial treatments are effica-
cious for the treatment of MNS disorders;
however, not all persons need all treat-
ments. The proposed packages recom-
mend stepped-care models where treat-
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Linked Neglected Diseases
Series
This Perspective introduces a new
series in PLoS Medicine on mental
health disorders in low- and middle-
income countries that reviews the
evidence for packages of care for
ADHD, alcohol misuse disorders,
dementia, depression, epilepsy,
and schizophrenia.
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ments are tailored to the needs of each
individual. People with almost all of these
disorders need continuing care and help to
maintain regular use of medication for
extended periods to achieve optimal
outcomes. In these respects, MNS disor-
ders are similar to other chronic condi-
tions, such as diabetes and cardiovascular
disease [9].
Nonspecialist health workers can deliv-
er, safely and effectively, treatments for
MNS disorders within a functioning pri-
mary health care system [10]. However,
collaborative care models, in which spe-
cialists play diverse roles of capacity
building, consultation, supervision, quality
assurance, and providing referral path-
ways greatly enhance the effectiveness and
sustainability of such nonspecialist health
worker-led care programs [11].
These shared characteristics suggest
that the packages of care for MNS
disorders can be integrated at three levels:
(1) packages catering to individual MNS
disorders can be integrated with each
other; (2) such packages can be integrated
with the treatment of other chronic
conditions; and (3) the packages can also
be integrated within the primary health
care system by strengthening its capacity
for management of chronic conditions
[9,12].
However, it is also clear that simply
making care available is not sufficient to
close the treatment gap; access will
continue to be hampered by stigma and
discrimination [6]. Building mental health
literacy and implementing strategies for
combating stigma and discrimination for
the whole population are critically impor-
tant.
It is also clear that, as with all chronic
conditions, most of the evidence is derived
from high-income countries. However, it is
heartening to note that where attempts to
replicate evidence on effectiveness have
been attempted in low and middle income
countries, the findings are consonant with
those from high income countries, sug-
gesting that such evidence may be gener-
alizable across cultures. While the pack-
ages of care published in PLoS Medicine can
provide clear guidelines to scaling up
services for people with MNS disorders,
there is a need to generate appropriate
evidence to guide the delivery of such
effective treatments and their scaling up
within routine health care delivery set-
tings. Research on culturally appropriate
and acceptable treatments, delivery and
scale-up is the now the most important
research priority for global mental health
[13].
We believe that the most innovative
aspect of this series is its focus on the
critically important element of ‘‘delivery.’’
To the best of our knowledge, the series is
the first attempt to collect comprehensive
reviews of six leading, and mostly neglect-
ed, MNS disorders in an open access
venue that allows immediate and full
access to everyone including those living
and working in low and middle income
countries. We hope this series serves as a
valuable resource for health professionals,
policy makers, and health workers working
to improve the care and treatment of those
struggling with MNS disorders in settings
where specialist resources are scarce and
where treatment gaps are large.
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